Outset Medical IncNASDAQ:OMNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6256
- TODAY'S CHANGE (%)-0.0061 (-0.9656%)
- Bid / Lots0.6255/ 13
- Ask / Lots0.6288/ 5
- Open / Previous Close0.6296 / 0.6317
- Day Range
- 52 Week Range
- Volume110,564
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OM |
|---|---|---|
| 09:32 ET | 10958 | 0.611 |
| 09:34 ET | 200 | 0.611 |
| 09:36 ET | 15340 | 0.6313 |
| 09:39 ET | 2000 | 0.63 |
| 09:41 ET | 100 | 0.6257 |
| 09:43 ET | 158 | 0.6257 |
| 09:45 ET | 400 | 0.611 |
| 09:50 ET | 600 | 0.611 |
| 09:52 ET | 16161 | 0.6101 |
| 09:54 ET | 600 | 0.6101 |
| 09:59 ET | 13259 | 0.6209 |
| 10:01 ET | 185 | 0.62095 |
| 10:06 ET | 600 | 0.6106 |
| 10:10 ET | 7326 | 0.6219 |
| 10:12 ET | 875 | 0.62 |
| 10:14 ET | 100 | 0.62 |
| 10:15 ET | 9261 | 0.62 |
| 10:17 ET | 640 | 0.6108 |
| 10:19 ET | 250 | 0.6108 |
| 10:24 ET | 715 | 0.6201 |
| 10:26 ET | 1587 | 0.6201 |
| 10:28 ET | 100 | 0.6201 |
| 10:30 ET | 100 | 0.6201 |
| 10:32 ET | 1569 | 0.62385 |
| 10:33 ET | 1570 | 0.625 |
| 10:39 ET | 756 | 0.6201 |
| 10:42 ET | 1727 | 0.62475 |
| 10:44 ET | 1385 | 0.6273 |
| 10:46 ET | 2473 | 0.6293 |
| 10:48 ET | 10304 | 0.6252 |
| 10:50 ET | 1200 | 0.6253 |
| 10:51 ET | 526 | 0.628827 |
| 10:57 ET | 500 | 0.6253 |
| 11:00 ET | 100 | 0.6288 |
| 11:02 ET | 605 | 0.6256 |
Today
Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 13 minutes ago by Dow Jones
13 minutes ago by Dow JonesShareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesOM Shareholders Have Opportunity to Lead Outset Medical, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
Yesterday
Levi & Korsinsky Reminds Outset Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - OM, from 14 hours ago by Dow Jones
14 hours ago by Dow JonesBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the Firm, from 14 hours ago by Dow Jones
14 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Outset Medical Inc | 32.9M | -0.2x | --- |
Harvard Bioscience Inc | 110.8M | -10.3x | --- |
ViewRay Inc | 180.0 | 0.0x | --- |
Fonar Corp | 106.4M | 10.7x | -7.15% |
Xylo Technologies Ltd | 2.2M | 0.0x | --- |
Vaso Corp | 33.3M | 12.3x | --- |
Company Information
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Contact Information
- Headquarters
- 3052 Orchard DriveSAN JOSE, CA, United States 95134
- Phone
- 971-563-3083
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Leslie Trigg
- Chief Financial Officer
- Nabeel Ahmed
- Senior Vice President - Operations and R&D
- Marc Nash
- General Counsel, Company Secretary
- John Brottem
- Lead Independent Director
- D. Keith Grossman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.9M |
|---|---|
Revenue (TTM) | $116.4M |
Shares Outstanding | 52.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.93 |
EPS | $-3.14 |
Book Value | $2.44 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -129.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
